Lila Perimenopause
Lila Perimenopause (often shortened to Lila) is an artificial intelligence-powered mobile health application developed by Amsterdam-based startup Tidalflow. Designed specifically for women aged 40 and above experiencing perimenopause, the app provides personalized nutrition coaching, symptom tracking, and weight management strategies targeting the hormonal changes associated with the menopause.[1][2]
Background: Perimenopause and Weight Management Challenges
The Hormonal Transition
Perimenopause, the transitional phase preceding menopause, typically begins in a woman's 40s and is characterized by fluctuating levels of estrogen, progesterone, and testosterone.[3] Unlike the gradual, linear hormone decline often assumed, perimenopause involves erratic hormonal fluctuations that create unpredictable symptoms and metabolic changes.[4]
During this transition, women experience a shift in fat distribution from peripheral areas (hips and thighs) to central abdominal regions, even when overall body weight remains stable. This change occurs due to declining estrogen levels and relative increases in androgen levels, creating what researchers term "android" fat distribution.[5]
Metabolic and Physiological Changes
Research indicates that perimenopausal weight gain results from multiple interconnected factors beyond simple caloric imbalance:
Metabolic Rate Decline: The natural slowing of basal metabolic rate occurs due to age-related muscle loss (sarcopenia) and hormonal changes, requiring dietary adjustments that many women are unaware of.[6]
Reduced Metabolic Flexibility: The body's ability to efficiently switch between glucose and fat as energy sources diminishes, leading to increased fat accumulation and reduced energy efficiency.[7]
Cortisol Dysregulation: The interconnected hypothalamic-pituitary-adrenal (HPA) and hypothalamic-pituitary-ovarian (HPO) axes mean that declining reproductive hormones affect stress hormone regulation, often increasing cortisol levels and promoting abdominal fat storage.[8]
Insulin Resistance Development: Visceral fat accumulation creates a pro-inflammatory state that impairs insulin signaling, increasing the risk of Type 2 diabetes and further weight gain.[9]
Gut Microbiome Changes: Emerging research shows that hormonal fluctuations alter gut bacteria composition, affecting estrogen metabolism and contributing to metabolic dysfunction.[10]
Product Features and Functionality
Core Technology
Lila utilizes artificial intelligence to provide personalized nutrition coaching through several integrated features:
AI Perimenopause Nutritionist: A conversational interface that adapts daily recommendations based on logged meals, symptoms, and individual response patterns. The system provides real-time coaching and evidence-based guidance tailored to hormonal fluctuations.[1]
Hormone-Aware Macro Tracking: Lila tracks macronutrients (protein, carbohydrates, fats) alongside fiber and omega-3 fatty acids, while identifying foods that may trigger or alleviate perimenopausal symptoms such as hot flashes.[11]
Symptom Relief Score: A visual analytics system that correlates dietary inputs with symptom patterns, helping users identify personal triggers and beneficial foods for managing fatigue, mood changes, and vasomotor symptoms.
Cycle-Based Meal Guidance: The application adjusts macronutrient recommendations based on hormonal phases, accounting for the different nutritional needs during follicular versus luteal phases of remaining menstrual cycles.
Scientific Basis and Evidence
Nutritional Intervention Research
Lila's recommendations are grounded in peer-reviewed research on perimenopause nutrition:
Protein Adequacy: Studies demonstrate that increased protein intake (1.2-1.6 grams per kilogram body weight) helps preserve lean muscle mass during hormonal transitions, supporting metabolic rate maintenance.[12]
Phytoestrogen Integration: Foods containing plant-based estrogens, such as soy products and flaxseeds, may help mitigate some effects of declining endogenous estrogen while supporting gut microbiome health.[13]
Anti-inflammatory Nutrition: Omega-3 fatty acids and fiber-rich foods help combat the low-grade inflammation associated with visceral fat accumulation and hormonal changes.[14]
Addressing Symptom Interconnectedness
Research shows that perimenopausal symptoms create reinforcing cycles. Poor sleep quality increases cortisol production, which promotes weight gain and mood disturbances. Mood changes can lead to emotional eating and reduced physical activity motivation, further exacerbating weight management challenges.[15]
Health Risks and Clinical Relevance
Cardiovascular and Metabolic Implications
The weight gain patterns that Lila addresses carry significant health consequences. Central adiposity during perimenopause increases cardiovascular disease risk, which becomes the leading cause of mortality for postmenopausal women.[16]
Visceral fat functions as an active endocrine organ, secreting pro-inflammatory cytokines including tumor necrosis factor-alpha and interleukin-6, while reducing production of protective adiponectin. This altered adipokine profile directly contributes to insulin resistance, dyslipidemia, and systemic inflammation.[17]
Broader Systemic Effects
Research indicates that untreated perimenopausal metabolic changes increase risks for:
- Type 2 diabetes mellitus
- Osteoporosis and fracture risk
- Alzheimer's disease and cognitive decline
- Autoimmune disorders
- Sleep disorders including sleep apnea[18]
Company and Development
Tidalflow Background
Tidalflow was founded by a former MIT Machine Learning student. The company's stated mission is to "redefine and democratize consumer health" through accessible AI-powered solutions.[19]
The company secured $1.7 million in seed funding in October 2023.[2]
Limitations of Conventional Weight Management During Perimenopause
Traditional weight loss approaches typically employ a "calories in, calories out" model that fails to account for the complex hormonal and metabolic changes of perimenopause. This approach often leads to frustration and abandonment among midlife women who find that previously successful strategies no longer work.[20]
Integrated Health Management
Lila's approach aligns with emerging medical consensus that effective perimenopausal care requires integrated management of nutrition, symptom tracking, stress management, and sleep optimization. This holistic methodology addresses the interconnected nature of perimenopausal symptoms rather than treating them as isolated issues.[21]
See also
- Perimenopause
- Menopause
- Hormone replacement therapy
- Women's health
- Mobile health
- Digital therapeutics
- Artificial intelligence in healthcare
- Metabolic syndrome
- Weight management
References
- ↑ 1.0 1.1 O'Hear, Steve (10 October 2023). "Tidalflow helps any software play nice with ChatGPT—and now targets women's health". TechCrunch. Retrieved 17 June 2025.
- ↑ 2.0 2.1 von Willebrand, Madelene (10 October 2023). "Amsterdam's Tidalflow raises €1.7 million". Tech.eu. Retrieved 17 June 2025.
- ↑ "Hormonal changes and metabolic risk during the menopausal transition". Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/jcem/dgae123 (inactive 1 July 2025).
- ↑ Appelman-Dijkstra, N. M.; Oei HLDW; Vlug, A. G.; Winter, E. M. (2023). "The menopausal transition: characteristics and management". Best Practice & Research Clinical Endocrinology & Metabolism. 37 (1). doi:10.1016/j.beem.2022.101623. PMID 35219602 Check
|pmid=value (help). - ↑ "Menopause and body composition changes". Climacteric. 26 (1): 1–8. 2023. doi:10.1080/13697137.2022.2098783 (inactive 1 July 2025).
- ↑ Costa GPO; Ferreira-Filho, E. S.; Simoes RDS; Soares-Junior, J. M.; Baracat, E. C.; Maciel GAR (2023). "Metabolic changes during menopause: a review". Maturitas. 167: 23–31. doi:10.1016/j.maturitas.2022.09.011. PMID 36368093 Check
|pmid=value (help). - ↑ "Metabolic flexibility in menopause". European Journal of Endocrinology. 188 (3). 2023. doi:10.1530/EJE-22-0891 (inactive 1 July 2025).
- ↑ Jha, M. K.; Chin Fatt, C. R.; Minhajuddin, A.; Mayes, T. L.; Berry, J. D.; Trivedi, M. H. (2023). "Cortisol and the menopausal transition". Psychoneuroendocrinology. 145. doi:10.1016/j.psyneuen.2022.105921. PMC 10177664 Check
|pmc=value (help). PMID 36126385 Check|pmid=value (help). - ↑ "Insulin resistance in menopause: metabolic changes and health implications". Diabetes Care. 46 (4): 850–862. 2023. doi:10.2337/dc22-1387 (inactive 1 July 2025).
- ↑ "The gut microbiome in menopause". Nature Reviews Endocrinology. 19 (6): 317–331. 2023. doi:10.1038/s41574-023-00838-1 (inactive 1 July 2025).
- ↑ "Lila – (Peri)Menopause". AppAdvice. Retrieved 17 June 2025.
- ↑ Martínez-Arias, L.; Fernández-Villabrille, S.; Alonso-Montes, C.; García-Navazo, G.; Ruíz-Torres, M. P.; Alajarín, R.; Alvarez-Builla, J.; Gutiérrez-Calabres, E.; Vaquero-López, J. J.; Carrillo-López, N.; Rodríguez-Puyol, D.; Cannata-Andía, J. B.; Panizo, S.; Naves-Díaz, M. (2023). "Protein requirements during menopause". Nutrients. 15 (8). doi:10.3390/nu15081820. PMC 10143556 Check
|pmc=value (help). PMID 37111038 Check|pmid=value (help). - ↑ Cittadini, N.; Basilici Zannetti, E.; Iovino, P.; De Maria, M.; d'Angelo, D.; Pennini, A.; Vellone, E.; Alvaro, R. (2022). "Phytoestrogens and menopausal symptoms: a systematic review". Maturitas. 159: 7–11. doi:10.1016/j.maturitas.2022.01.013. PMID 35688499 Check
|pmid=value (help). - ↑ "Anti-inflammatory diet in menopause". Current Opinion in Clinical Nutrition & Metabolic Care. 26 (3): 259–265. 2023. doi:10.1097/MCO.0000000000000923.
- ↑ "The interconnected nature of perimenopausal symptoms". Menopause. 30 (5): 487–495. 2023. doi:10.1097/GME.0000000000002157. PMID 36749915 Check
|pmid=value (help). - ↑ Dibben, G. O.; Faulkner, J.; Oldridge, N.; Rees, K.; Thompson, D. R.; Zwisler, A. D.; Taylor, R. S. (2023). "Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis". European Heart Journal. 44 (12): 1175–1185. doi:10.1093/eurheartj/ehac747. PMC 9902155 Check
|pmc=value (help). PMID 36746187 Check|pmid=value (help). - ↑ "Adipose tissue dysfunction in menopause". Nature Reviews Endocrinology. 18 (11): 685–700. 2022. doi:10.1038/s41574-022-00719-7 (inactive 1 July 2025).[AI-generated?]
- ↑ "Long-term health consequences of menopausal transition". The Lancet. 401 (10374): 454–468. 2023. doi:10.1016/S0140-6736(22)02613-1 (inactive 1 July 2025).[AI-generated?]
- ↑ "Linkedin". Linkedin. Retrieved 17 June 2025.
- ↑ "Weight management in midlife women: current approaches and challenges". Obesity Reviews. 24 (3). 2023. doi:10.1111/obr.13521.
- ↑ Matsiras, D.; Bezati, S.; Ventoulis, I.; Verras, C.; Parissis, J.; Polyzogopoulou, E. (2023). "Integrative approaches to menopausal care". Journal of Clinical Medicine. 12 (7). doi:10.3390/jcm12072567. PMC 10095379 Check
|pmc=value (help). PMID 37048650 Check|pmid=value (help).
External links
This article "Lila Perimenopause" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Lila Perimenopause. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
